SeaChange Pharmaceuticals is a company developing chemoinformatic and statistical methods to predict drug side effects and new therapeutic opportunities. It provides SEAware, a software package that uses the similarity ensemble approach (SEA) to reduce the likelihood of drug failure in clinical studies and the need for toxicity testing in animals.